Postischemic microvasculopathy and endothelial progenitor cell-based therapy in ischemic AKI: update and perspectives

被引:17
|
作者
Patschan, D. [1 ]
Kribben, A. [2 ]
Mueller, G. A. [1 ]
机构
[1] Univ Gottingen, Univ Hosp Gottingen, Clin Nephrol & Rheumatol, Gottingen, Germany
[2] Univ Duisburg Essen, Univ Hosp Essen, Dept Nephrol, Essen, Germany
关键词
acute kidney injury; EPCs; microvasculopathy; ACUTE-RENAL-FAILURE; ACUTE KIDNEY INJURY; MESENCHYMAL STEM-CELLS; CISPLATIN-INDUCED NEPHROTOXICITY; REPERFUSION INJURY; MITOCHONDRIAL INJURY; BARRIER FUNCTION; PROXIMAL TUBULE; POTENTIAL ROLE; RAT MODEL;
D O I
10.1152/ajprenal.00232.2016
中图分类号
Q4 [生理学];
学科分类号
071003 ;
摘要
Acute kidney injury (AKI) dramatically increases mortality of hospitalized patients. Incidences have been increased in recent years. The most frequent cause is transient renal hypoperfusion or ischemia which induces significant tubular cell dysfunction/damage. In addition, two further events take place: interstitial inflammation and microvasculopathy (MV). The latter evolves within minutes to hours postischemia and may result in permanent deterioration of the peritubular capillary network, ultimately increasing the risk for chronic kidney disease (CKD) in the long term. In recent years, our understanding of the molecular/cellular processes responsible for acute and sustained microvasculopathy has increasingly been expanded. The methodical approaches for visualizing impaired peritubular blood flow and increased vascular permeability have been optimized, even allowing the depiction of tissue abnormalities in a three-dimensional manner. In addition, endothelial dysfunction, a hallmark of MV, has increasingly been recognized as an inductor of both vascular malfunction and interstitial inflammation. In this regard, so-called regulated necrosis of the endothelium could potentially play a role in postischemic inflammation. Endothelial progenitor cells (EPCs), represented by at least two major subpopulations, have been shown to promote vascular repair in experimental AKI, not only in the short but also in the long term. The discussion about the true biology of the cells continues. It has been proposed that early EPCs are most likely myelomonocytic in nature, and thus they may simply be termed proangiogenic cells (PACs). Nevertheless, they reliably protect certain types of tissues/organs from ischemia-induced damage, mostly by modulating the perivascular microenvironment in an indirect manner. The aim of the present review is to summarize the current knowledge on postischemic MV and EPC-mediated renal repair.
引用
收藏
页码:F382 / F394
页数:13
相关论文
共 50 条
  • [41] Endothelial progenitor cells: the promise of cell-based therapies for acute lung injury
    Mao, Mei
    Xu, Xilin
    Zhang, Yong
    Zhang, Bo
    Fu, Zu-hong
    INFLAMMATION RESEARCH, 2013, 62 (01) : 3 - 8
  • [42] New perspectives of tissue remodelling with neural stem and progenitor cell-based therapies
    Cossetti, Chiara
    Alfaro-Cervello, Clara
    Donega, Matteo
    Tyzack, Giulia
    Pluchino, Stefano
    CELL AND TISSUE RESEARCH, 2012, 349 (01) : 321 - 329
  • [43] New perspectives of tissue remodelling with neural stem and progenitor cell-based therapies
    Chiara Cossetti
    Clara Alfaro-Cervello
    Matteo Donegà
    Giulia Tyzack
    Stefano Pluchino
    Cell and Tissue Research, 2012, 349 : 321 - 329
  • [44] Fibromodulin reprogrammed progenitor cell-based therapy for skeletal muscle generation
    Zheng, Zhong
    Yang, Pu
    Velasco, Omar
    Lord, Elisabeth
    Khalilinejad, Kambiz
    Yue, Olivia
    Murphy, Maxwell
    Kim, Soyon
    Lee, Min
    Zhang, Xinli
    Ting, Kang
    Soo, Chia
    JOURNAL OF BONE AND MINERAL RESEARCH, 2014, 29 : S488 - S488
  • [45] Stem and progenitor cell-based therapy of the human central nervous system
    Goldman, S
    NATURE BIOTECHNOLOGY, 2005, 23 (07) : 862 - 871
  • [46] Stem cell-based therapy of corneal epithelial and endothelial diseases
    Yuan, Songtao
    Fan, Guoping
    REGENERATIVE MEDICINE, 2015, 10 (04) : 495 - 504
  • [47] Endothelial cell-based systemic gene therapy of metastatic melanoma
    Ojeifo, JO
    Lee, HR
    Rezza, P
    Su, N
    Zwiebel, JA
    CANCER GENE THERAPY, 2001, 8 (09) : 636 - 648
  • [48] Current status and perspectives of regulatory T cell-based therapy
    Guojun Qu
    Jieqiong Chen
    Yangyang Li
    Yaqin Yuan
    Rui Liang
    Bin Li
    Journal of Genetics and Genomics, 2022, 49 (07) : 599 - 611
  • [49] Current status and perspectives of regulatory T cell-based therapy
    Qu, Guojun
    Chen, Jieqiong
    Li, Yangyang
    Yuan, Yaqin
    Liang, Rui
    Li, Bin
    JOURNAL OF GENETICS AND GENOMICS, 2022, 49 (07) : 599 - 611